Criteria of PCOS has chased several times

Polycystic Ovary Syndrome: Definitions have been amended many a times and in view of my age I can't recollected the different criteria of PCO as suggested by many academic bodies/committee opinions. You being very young. I hope you remember that criteria of PCO and it's ill-effects on fertility and metabolic diseases have been modified at least half-a-dozen times!!!😭😭😭

------------------------------------------------------------------------------------------------

PCOS is arguably one of the most common endocrine disorders in women of reproductive age, affecting 5% to 10% of women worldwide. This familial disorder appears to be inherited as a complex genetic trait . It is characterized by a combination of hyperandrogenism (either clinical or biochemical), chronic anovulation, and polycystic ovaries. It is frequently associated with insulin resistance and obesity. PCOS receives considerable attention because of its using the Rotterdam PCOS Diagnostic Criteria, the presence of two of the three criteria is sufficient to diagnosis PCOS; menstrual cycle anomalies (amenorrhoea, oligomenorrhea), clinical and/or biochemical hyperandrogenism, and/or the ultrasound appearance of polycystic ovaries after all other diagnoses are ruled out. Other pathologies that can result in a PCOS phenotype include AOAH, adrenal or ovarian neoplasm, Cushing syndrome, hypo or hypergonadotropic disorders, hyperprolactinemia, and thyroid disease

All other frequently encountered manifestations offer less consistent findings and therefore qualify only as minor diagnostic criteria for PCOS. They include elevated LH-to-FSH (follicle-stimulating hormone) ratio, insulin resistance, perimenarchal onset of hirsutism, and obesity.

Clinical hyperandrogenism includes hirsutism, male pattern alopecia, and acne. Hirsutism occurs in approximately 70% of patients with PCOS in the United States and in only 10% to 20% of patients with PCOS in Japan. A likely explanation for this discrepancy is the genetically determined differences in skin 5a-reducates activity.

Nonclassic adrenal hyperplasia and PCOS may present with similar clinical features. It is important to measure the basal follicular phase 17-hydroxyprogesterone level in all women presenting.

From Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Polycystic Ovary Syndrome: Definitions have been amended many a times and in view of my age I can't recollected the different criteria of PCO as suggested by many academic bodies/committee opinions. You being very young. I hope you remember that criteria of PCO and it's ill-effects on fertility and metabolic diseases have been modified at least half-a-dozen times!!!😭😭😭

------------------------------------------------------------------------------------------------

PCOS is arguably one of the most common endocrine disorders in women of reproductive age, affecting 5% to 10% of women worldwide. This familial disorder appears to be inherited as a complex genetic trait . It is characterized by a combination of hyperandrogenism (either clinical or biochemical), chronic anovulation, and polycystic ovaries. It is frequently associated with insulin resistance and obesity. PCOS receives considerable attention because of its using the Rotterdam PCOS Diagnostic Criteria, the presence of two of the three criteria is sufficient to diagnosis PCOS; menstrual cycle anomalies (amenorrhoea, oligomenorrhea), clinical and/or biochemical hyperandrogenism, and/or the ultrasound appearance of polycystic ovaries after all other diagnoses are ruled out. Other pathologies that can result in a PCOS phenotype include AOAH, adrenal or ovarian neoplasm, Cushing syndrome, hypo or hypergonadotropic disorders, hyperprolactinemia, and thyroid disease

All other frequently encountered manifestations offer less consistent findings and therefore qualify only as minor diagnostic criteria for PCOS. They include elevated LH-to-FSH (follicle-stimulating hormone) ratio, insulin resistance, perimenarchal onset of hirsutism, and obesity.

Clinical hyperandrogenism includes hirsutism, male pattern alopecia, and acne. Hirsutism occurs in approximately 70% of patients with PCOS in the United States and in only 10% to 20% of patients with PCOS in Japan. A likely explanation for this discrepancy is the genetically determined differences in skin 5a-reducates activity.

Nonclassic adrenal hyperplasia and PCOS may present with similar clinical features. It is important to measure the basal follicular phase 17-hydroxyprogesterone level in all women presenting.

From Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Polycystic Ovary Syndrome: Definitions have been amended many a times and in view of my age I can't recollected the different criteria of PCO as suggested by many academic bodies/committee opinions. You being very young. I hope you remember that criteria of PCO and it's ill-effects on fertility and metabolic diseases have been modified at least half-a-dozen times!!!😭😭😭

------------------------------------------------------------------------------------------------

PCOS is arguably one of the most common endocrine disorders in women of reproductive age, affecting 5% to 10% of women worldwide. This familial disorder appears to be inherited as a complex genetic trait . It is characterized by a combination of hyperandrogenism (either clinical or biochemical), chronic anovulation, and polycystic ovaries. It is frequently associated with insulin resistance and obesity. PCOS receives considerable attention because of its using the Rotterdam PCOS Diagnostic Criteria, the presence of two of the three criteria is sufficient to diagnosis PCOS; menstrual cycle anomalies (amenorrhoea, oligomenorrhea), clinical and/or biochemical hyperandrogenism, and/or the ultrasound appearance of polycystic ovaries after all other diagnoses are ruled out. Other pathologies that can result in a PCOS phenotype include AOAH, adrenal or ovarian neoplasm, Cushing syndrome, hypo or hypergonadotropic disorders, hyperprolactinemia, and thyroid disease

All other frequently encountered manifestations offer less consistent findings and therefore qualify only as minor diagnostic criteria for PCOS. They include elevated LH-to-FSH (follicle-stimulating hormone) ratio, insulin resistance, perimenarchal onset of hirsutism, and obesity.

Clinical hyperandrogenism includes hirsutism, male pattern alopecia, and acne. Hirsutism occurs in approximately 70% of patients with PCOS in the United States and in only 10% to 20% of patients with PCOS in Japan. A likely explanation for this discrepancy is the genetically determined differences in skin 5a-reducates activity.

Nonclassic adrenal hyperplasia and PCOS may present with similar clinical features. It is important to measure the basal follicular phase 17-hydroxyprogesterone level in all women presenting.

From Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.